4421 studies found for:    stem cell
Show Display Options
Rank Status Study
1 Recruiting Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
Conditions: Hematopoietic Stem Cell Transplantation;   Mesenchymal Stem Cells;   Umbilical Cord Blood;   Graft Failure;   Hematological Diseases
Interventions: Biological: Mesenchymal stem cells;   Biological: Mesenchymal stem cells and cord blood
2 Recruiting Stem Cell Educator Therapy in Alopecia Areata
Condition: Alopecia Areata
Intervention: Device: Stem Cell Educator
3 Recruiting Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant
Conditions: Stem Cell Transplantation, Hematopoietic;   Mesenchymal Stem Cells;   Poor Graft Function;   Hematological Diseases
Intervention: Biological: Mesenchymal stem cells
4 Terminated
Has Results
Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft
Conditions: ALL;   ANLL;   MDS;   NHL
Interventions: Procedure: Naive T-cell Depleted Stem Cell Transplant;   Procedure: Stem Cell Transplant No Manipulation;   Device: Isolex device from Baxter
5 Terminated The Application of Cultured Cornea Stem Cells in Patients Suffering From Corneal Stem Cell Insufficiency
Condition: Unilateral Limbal Stem Cell Insufficiency
Intervention: Procedure: Transplant of cultured limbal stem cells on cornea
6 Active, not recruiting Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant
Condition: Multiple Myeloma
Intervention: Procedure: Fractionated Stem Cell Infusions
7 Recruiting Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM
Condition: Type 2 Diabetes Mellitus
Interventions: Other: Stem cell therapy- SPD artery;   Other: Stem cell therapy- splenic artery;   Other: Stem cell therapy-intravenous;   Other: Normal saline placebo -sham procedure
8 Completed Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Secondary AML;   Myelodysplastic Syndrome (MDS);   Secondary MDS;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia (JMML);   Paroxysmal Nocturnal Hemoglobinuria (PNH);   Lymphoma, Non-Hodgkin;   Hodgkin Disease
Interventions: Procedure: Stem Cell Transplantation;   Device: Miltenyi Biotec CliniMACS;   Drug: Systemic chemotherapy and antibodies
9 Withdrawn RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Procedure: hematopoietic stem cell mobilization;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Other: laboratory biomarker analysis
10 Not yet recruiting Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting
Condition: Nonunion Fracture
Interventions: Biological: Mesenchymal Stem Cells;   Other: Culture medium without MSC.
11 Active, not recruiting Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency
Condition: Limbal Stem Cell Deficiency
Intervention: Procedure: Cultivated limbal stem cell graft transplantation
12 Completed Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemias;   Acute Myelocytic Leukemia;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Hemoglobinuria, Paroxysmal;   Non-Hodgkin Lymphoma
Interventions: Procedure: Allogeneic Stem Cell Transplantation;   Drug: Chemotherapy and antibodies
13 Active, not recruiting Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Conditions: Breast Cancer;   Bone Metastases
Interventions: Drug: 153 Sm-EDTMP;   Behavioral: Questionnaire;   Procedure: Stem Cell Transplant
14 Active, not recruiting Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome
Condition: Limbus Corneae Insufficiency Syndrome
Intervention: Procedure: Stem Cell with Amniotic Membrane Transplant
15 Completed CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction
Conditions: Recent Myocardial Infarction;   Ventricular Dysfunction
Intervention: Biological: Autologous stem cell infusion
16 Recruiting Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy
Condition: Type 1 Diabetes
Intervention: Device: Stem Cell Educator
17 Completed Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
Conditions: Leukemia;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria;   Hodgkin's Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Drug: Systematic chemotherapy and antibodies;   Procedure: Allogeneic stem cell transplantation;   Device: Miltenyi CliniMACS
18 Terminated T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
Conditions: Leukemia;   Hodgkin Lymphoma;   Non Hodgkin Lymphoma;   Myeloproliferative Disorders
Interventions: Drug: ARA C;   Drug: Cyclophosphamide;   Drug: MESNA;   Radiation: Total Body Irradiation (TBI);   Biological: Campath-1h;   Procedure: Stem Cell Infusion
19 Completed Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
Conditions: Allogeneic Stem Cell Transplant;   Leukemia;   Non-Hodgkins;   Lymphoblastic Lymphoma;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention: Drug: cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
20 Active, not recruiting Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma
Condition: Lymphoma
Interventions: Biological: lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Procedure: autologous hematopoietic stem cell transplantation

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years